Text Size

T Regulatory and Childhood Asthma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00204828
First received: September 12, 2005
Last updated: December 12, 2012
Last verified: December 2012
History of Changes
  Purpose

This is an epidemiologic study, examining environmental exposures and affect on immune development.


Condition
Childhood Asthma

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: T Regulatory and Childhood Asthma

Resource links provided by NLM:

MedlinePlus related topics: Asthma
U.S. FDA Resources

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Childhood asthma [ Time Frame: 3 years ] [ Designated as safety issue: No ]
  • Allergic sensitization [ Time Frame: 3 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

blood, PBMC culture supes and nasal lavage


Enrollment: 58
Study Start Date: October 2005
Estimated Study Completion Date: December 2013
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts
1.
Children with asthma
2.
Children without asthma

Detailed Description:

This is an epidemiologic study, examining environmental exposures and affect on immune development. The study has completed enrollment

  Eligibility

Ages Eligible for Study:   6 Years to 7 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

6-7 yo children of either gender

Criteria

Inclusion Criteria:

  • moderate to severe asthma

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00204828

Locations
United States, Wisconsin
University of Wisconsin
Madison, Wisconsin, United States, 53792
Sponsors and Collaborators
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
Principal Investigator: James Gern, MD University of Wisconsin, Madison
  More Information

Additional Information:
Related Info  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00204828     History of Changes
Other Study ID Numbers: 2004-0224, RO1 HL080072
Study First Received: September 12, 2005
Last Updated: December 12, 2012
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
 Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 21, 2013